Press Release: Monday 13 July
Minister for Health Presents Ireland’s Health Programme for the Presidency of the Council of the European Union to MEPs on the European Parliament’s Committee on Public Health (SANT)
The Minister for Health, Jennifer Carroll MacNeill TD, today appeared before Members of the European Parliament (MEPs) on the European Parliament’s Committee on Public Health (SANT).
Minister Carroll MacNeill discussed Ireland’s EU Presidency Health Programme, legislative priorities and objectives with MEPs at today’s hearings. These priorities include the Biotech Act and the simplification of the Medical Devices and In Vitro Diagnostics Regulations – both of which, when enacted, will result in better access to medicines and medtech devices for patients. During the Irish Presidency, discussions will also support the implementation of the European Health Data Space, advancing Europe’s Beating Cancer Plan, as well as promoting improved mental health policies.
Minister Carroll MacNeill, said:
“I am grateful to the SANT Committee for their engagement with me today on Ireland’s Presidency of the Council of the European Union.
“At a time of geopolitical uncertainty, health security threats, demographic change and pressure on public finances, cooperation at European level on health has never been more important. Ireland is committed to delivering a Presidency that is fair, pragmatic and focused on results for patients across Europe.
“Healthier populations, resilient health services, innovation and a predictable regulatory environment are fundamental to Europe’s economic and social strength. Health policy will play a pivotal role in advancing the Irish Presidency’s priorities of values, security and competitiveness, by working to progress key files that support innovation and patient safety, including the Biotech Act, and the simplification of the Medical Devices and In Vitro Diagnostics Regulations.
“We know that cardiovascular disease claims 1.7 million lives across the EU every year. Alongside Health Checks, we must do more to prevent disease before it starts. We look forward to the Commission’s proposed revision of the Tobacco Products Directive and to advancing discussions on how investment in health can contribute to both better outcomes for citizens and a more competitive and healthier Europe.”